Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics of Treatment Responders to Galantamine Administration in the Patients With Alzheimer's Disease

NCT01029132 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01029132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01029132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics of Treatment Responders to Galantamine Administration in the Patients With Alzheimer's Disease
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2007
Completion date
October 31, 2009
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia